Copyright Reports & Markets. All rights reserved.

Global Human Insulin Market Professional Survey Report 2019

Request for Sample of this report
Buy now

Table of Contents

    Executive Summary

      1 Industry Overview of Human Insulin

      • 1.1 Definition of Human Insulin
      • 1.2 Human Insulin Segment by Type
        • 1.2.1 Global Human Insulin Production Growth Rate Comparison by Types (2014-2025)
        • 1.2.2 Insulin Analogs and Biosimilars
        • 1.2.3 Human Insulin Biologics
      • 1.3 Human Insulin Segment by Applications
        • 1.3.1 Global Human Insulin Consumption Comparison by Applications (2014-2025)
        • 1.3.2 Short acting
        • 1.3.3 Intermediate acting
        • 1.3.4 Long acting
        • 1.3.5 Pre-mix Insulin
      • 1.4 Global Human Insulin Overall Market
        • 1.4.1 Global Human Insulin Revenue (2014-2025)
        • 1.4.2 Global Human Insulin Production (2014-2025)
        • 1.4.3 North America Human Insulin Status and Prospect (2014-2025)
        • 1.4.4 Europe Human Insulin Status and Prospect (2014-2025)
        • 1.4.5 China Human Insulin Status and Prospect (2014-2025)
        • 1.4.6 Japan Human Insulin Status and Prospect (2014-2025)
        • 1.4.7 Southeast Asia Human Insulin Status and Prospect (2014-2025)
        • 1.4.8 India Human Insulin Status and Prospect (2014-2025)

      2 Manufacturing Cost Structure Analysis

      • 2.1 Raw Material and Suppliers
      • 2.2 Manufacturing Cost Structure Analysis of Human Insulin
      • 2.3 Manufacturing Process Analysis of Human Insulin
      • 2.4 Industry Chain Structure of Human Insulin

      3 Development and Manufacturing Plants Analysis of Human Insulin

      • 3.1 Capacity and Commercial Production Date
      • 3.2 Global Human Insulin Manufacturing Plants Distribution
      • 3.3 Major Manufacturers Technology Source and Market Position of Human Insulin
      • 3.4 Recent Development and Expansion Plans

      4 Key Figures of Major Manufacturers

      • 4.1 Human Insulin Production and Capacity Analysis
      • 4.2 Human Insulin Revenue Analysis
      • 4.3 Human Insulin Price Analysis
      • 4.4 Market Concentration Degree

      5 Human Insulin Regional Market Analysis

      • 5.1 Human Insulin Production by Regions
        • 5.1.1 Global Human Insulin Production by Regions
        • 5.1.2 Global Human Insulin Revenue by Regions
      • 5.2 Human Insulin Consumption by Regions
      • 5.3 North America Human Insulin Market Analysis
        • 5.3.1 North America Human Insulin Production
        • 5.3.2 North America Human Insulin Revenue
        • 5.3.3 Key Manufacturers in North America
        • 5.3.4 North America Human Insulin Import and Export
      • 5.4 Europe Human Insulin Market Analysis
        • 5.4.1 Europe Human Insulin Production
        • 5.4.2 Europe Human Insulin Revenue
        • 5.4.3 Key Manufacturers in Europe
        • 5.4.4 Europe Human Insulin Import and Export
      • 5.5 China Human Insulin Market Analysis
        • 5.5.1 China Human Insulin Production
        • 5.5.2 China Human Insulin Revenue
        • 5.5.3 Key Manufacturers in China
        • 5.5.4 China Human Insulin Import and Export
      • 5.6 Japan Human Insulin Market Analysis
        • 5.6.1 Japan Human Insulin Production
        • 5.6.2 Japan Human Insulin Revenue
        • 5.6.3 Key Manufacturers in Japan
        • 5.6.4 Japan Human Insulin Import and Export
      • 5.7 Southeast Asia Human Insulin Market Analysis
        • 5.7.1 Southeast Asia Human Insulin Production
        • 5.7.2 Southeast Asia Human Insulin Revenue
        • 5.7.3 Key Manufacturers in Southeast Asia
        • 5.7.4 Southeast Asia Human Insulin Import and Export
      • 5.8 India Human Insulin Market Analysis
        • 5.8.1 India Human Insulin Production
        • 5.8.2 India Human Insulin Revenue
        • 5.8.3 Key Manufacturers in India
        • 5.8.4 India Human Insulin Import and Export

      6 Human Insulin Segment Market Analysis (by Type)

      • 6.1 Global Human Insulin Production by Type
      • 6.2 Global Human Insulin Revenue by Type
      • 6.3 Human Insulin Price by Type

      7 Human Insulin Segment Market Analysis (by Application)

      • 7.1 Global Human Insulin Consumption by Application
      • 7.2 Global Human Insulin Consumption Market Share by Application (2014-2019)

      8 Human Insulin Major Manufacturers Analysis

      • 8.1 B. Braun
        • 8.1.1 B. Braun Human Insulin Production Sites and Area Served
        • 8.1.2 B. Braun Product Introduction, Application and Specification
        • 8.1.3 B. Braun Human Insulin Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
        • 8.1.4 Main Business and Markets Served
      • 8.2 Becton, Dickinson
        • 8.2.1 Becton, Dickinson Human Insulin Production Sites and Area Served
        • 8.2.2 Becton, Dickinson Product Introduction, Application and Specification
        • 8.2.3 Becton, Dickinson Human Insulin Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
        • 8.2.4 Main Business and Markets Served
      • 8.3 Biocon
        • 8.3.1 Biocon Human Insulin Production Sites and Area Served
        • 8.3.2 Biocon Product Introduction, Application and Specification
        • 8.3.3 Biocon Human Insulin Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
        • 8.3.4 Main Business and Markets Served
      • 8.4 Biodel
        • 8.4.1 Biodel Human Insulin Production Sites and Area Served
        • 8.4.2 Biodel Product Introduction, Application and Specification
        • 8.4.3 Biodel Human Insulin Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
        • 8.4.4 Main Business and Markets Served
      • 8.5 ELI Lilly
        • 8.5.1 ELI Lilly Human Insulin Production Sites and Area Served
        • 8.5.2 ELI Lilly Product Introduction, Application and Specification
        • 8.5.3 ELI Lilly Human Insulin Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
        • 8.5.4 Main Business and Markets Served
      • 8.6 Julphar
        • 8.6.1 Julphar Human Insulin Production Sites and Area Served
        • 8.6.2 Julphar Product Introduction, Application and Specification
        • 8.6.3 Julphar Human Insulin Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
        • 8.6.4 Main Business and Markets Served
      • 8.7 NOVO Nordisk
        • 8.7.1 NOVO Nordisk Human Insulin Production Sites and Area Served
        • 8.7.2 NOVO Nordisk Product Introduction, Application and Specification
        • 8.7.3 NOVO Nordisk Human Insulin Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
        • 8.7.4 Main Business and Markets Served
      • 8.8 Sanofi
        • 8.8.1 Sanofi Human Insulin Production Sites and Area Served
        • 8.8.2 Sanofi Product Introduction, Application and Specification
        • 8.8.3 Sanofi Human Insulin Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
        • 8.8.4 Main Business and Markets Served
      • 8.9 Wockhardt
        • 8.9.1 Wockhardt Human Insulin Production Sites and Area Served
        • 8.9.2 Wockhardt Product Introduction, Application and Specification
        • 8.9.3 Wockhardt Human Insulin Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
        • 8.9.4 Main Business and Markets Served
      • 8.10 Ypsomed
        • 8.10.1 Ypsomed Human Insulin Production Sites and Area Served
        • 8.10.2 Ypsomed Product Introduction, Application and Specification
        • 8.10.3 Ypsomed Human Insulin Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
        • 8.10.4 Main Business and Markets Served

      9 Development Trend of Analysis of Human Insulin Market

      • 9.1 Global Human Insulin Market Trend Analysis
        • 9.1.1 Global Human Insulin Market Size (Volume and Value) Forecast 2019-2025
      • 9.2 Human Insulin Regional Market Trend
        • 9.2.1 North America Human Insulin Forecast 2019-2025
        • 9.2.2 Europe Human Insulin Forecast 2019-2025
        • 9.2.3 China Human Insulin Forecast 2019-2025
        • 9.2.4 Japan Human Insulin Forecast 2019-2025
        • 9.2.5 Southeast Asia Human Insulin Forecast 2019-2025
        • 9.2.6 India Human Insulin Forecast 2019-2025
      • 9.3 Human Insulin Market Trend (Product Type)
      • 9.4 Human Insulin Market Trend (Application)
      • 10.1 Marketing Channel
        • 10.1.1 Direct Marketing
        • 10.1.2 Indirect Marketing
      • 10.3 Human Insulin Customers

      11 Market Dynamics

      • 11.1 Market Trends
      • 11.2 Opportunities
      • 11.3 Market Drivers
      • 11.4 Challenges
      • 11.5 Influence Factors

      12 Conclusion

        13 Appendix

        • 13.1 Methodology/Research Approach
          • 13.1.1 Research Programs/Design
          • 13.1.2 Market Size Estimation
          • 13.1.3 Market Breakdown and Data Triangulation
        • 13.2 Data Source
          • 13.2.1 Secondary Sources
          • 13.2.2 Primary Sources
        • 13.3 Author List

        Human insulin is the name which describes synthetic insulin which is laboratory grown to mimic the insulin in humans.
        In 2018, North America is estimated to dominate the global human insulin market. The Asia-Pacific market is poised to grow the fastest, during the forecast period, owing to growing diabetes prevalence in APAC (coupled with large diabetic & pre-diabetic patient population), strengthening distribution networks of global product manufacturers in the region, evolving regulatory framework for marketing approvals & medical reimbursements, continued expansion of advanced medical facilities in emerging countries (such as China & India), and rising public awareness related to benefits offered by human insulin in diabetes treatment.

        The global Human Insulin market was valued at xx million US$ in 2018 and will reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025.
        This report focuses on Human Insulin volume and value at global level, regional level and company level. From a global perspective, this report represents overall Human Insulin market size by analyzing historical data and future prospect.
        Regionally, this report categorizes the production, apparent consumption, export and import of Human Insulin in North America, Europe, China, Japan, Southeast Asia and India.
        For each manufacturer covered, this report analyzes their Human Insulin manufacturing sites, capacity, production, ex-factory price, revenue and market share in global market.

        The following manufacturers are covered:
        B. Braun
        Becton, Dickinson
        Biocon
        Biodel
        ELI Lilly
        Julphar
        NOVO Nordisk
        Sanofi
        Wockhardt
        Ypsomed

        Segment by Regions
        North America
        Europe
        China
        Japan
        Southeast Asia
        India

        Segment by Type
        Insulin Analogs and Biosimilars
        Human Insulin Biologics

        Segment by Application
        Short acting
        Intermediate acting
        Long acting
        Pre-mix Insulin

        Buy now